Itron (NASDAQ:ITRI) Rating Increased to Strong-Buy at Zacks Research

Itron (NASDAQ:ITRI) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Tuesday,Zacks.com reports. Zacks Research also issued estimates for Itron’s Q4 2026 earnings at $1.53 EPS, FY2026 earnings at $6.03 EPS and Q3 2027 earnings at $1.79 EPS.

Several other research firms have also recently weighed in on ITRI. Guggenheim reissued a “buy” rating and set a $155.00 price target (up from $133.00) on shares of Itron in a report on Monday, July 14th. Stephens reissued an “equal weight” rating and set a $130.00 price target on shares of Itron in a report on Tuesday, October 7th. Johnson Rice cut Itron from a “buy” rating to an “accumulate” rating in a report on Friday, August 1st. Roth Capital lifted their price target on Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Finally, Wall Street Zen raised Itron from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $137.10.

Itron Stock Performance

Shares of NASDAQ ITRI opened at $133.72 on Tuesday. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. Itron has a 12 month low of $90.11 and a 12 month high of $140.04. The stock has a 50 day moving average of $123.77 and a 200-day moving average of $120.29. The company has a market capitalization of $6.11 billion, a P/E ratio of 22.86, a P/E/G ratio of 0.72 and a beta of 1.48.

Itron (NASDAQ:ITRI) last issued its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. During the same period in the previous year, the company posted $1.21 EPS. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, equities research analysts predict that Itron will post 5.33 EPS for the current year.

Insider Activity at Itron

In other news, CFO Joan S. Hooper sold 970 shares of the business’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $121,550.70. Following the completion of the transaction, the chief financial officer owned 88,394 shares of the company’s stock, valued at approximately $11,076,652.14. The trade was a 1.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP John F. Marcolini sold 565 shares of the business’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the transaction, the senior vice president directly owned 14,396 shares of the company’s stock, valued at $1,803,962.76. This trade represents a 3.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,037 shares of company stock worth $380,566 in the last three months. Insiders own 1.45% of the company’s stock.

Hedge Funds Weigh In On Itron

A number of institutional investors have recently modified their holdings of ITRI. Twin Peaks Wealth Advisors LLC acquired a new position in Itron in the 2nd quarter worth about $30,000. Bessemer Group Inc. increased its holdings in Itron by 125.7% in the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock worth $34,000 after purchasing an additional 142 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in Itron by 343.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after purchasing an additional 268 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares in the last quarter. Finally, REAP Financial Group LLC increased its holdings in Itron by 168.4% in the 2nd quarter. REAP Financial Group LLC now owns 424 shares of the scientific and technical instruments company’s stock worth $56,000 after purchasing an additional 266 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.